Pinealon

Pinealon is the tripeptide Glu-Asp-Arg, indexed by the US National Library of Medicine as "T-33 peptide" with the scope note that it increases cell viability by suppressing free radical levels. Despite the name it is not a pineal hormone and contains no melatonin; the pineal reference is to the tissue the St. Petersburg group worked from, not to anything the peptide does.

What distinguishes it from its siblings is that its central finding appeared in an English-language international journal rather than only in Russian house journals — which raises its visibility without making the work any less preclinical.

The claim is antioxidant plus genomic. Across cerebellar granule cells, neutrophils and PC12 pheochromocytoma cells, EDR produced dose-dependent restriction of reactive oxygen species accumulation under oxidative stress, reduced necrotic death and shifted the cell cycle; the authors went on to propose direct interaction with the genome ( Khavinson et al., Rejuvenation Res 2011;14(5):535-41). Labelled EDR was separately seen entering the nucleolus of HeLa cells ( Fedoreyeva et al., Biochemistry (Mosc) 2011). Cultured neurons under artificial oxidative challenge are a long way from a human brain behind an intact blood-brain barrier.

No neurology guideline lists this peptide, and it holds no indication for cognitive decline, dementia, stroke or brain injury. The nearest animal disease model is a study in rat offspring exposed to prenatal hyperhomocysteinaemia ( Bull Exp Biol Med 2012) — a narrow developmental insult, not a model of age-related cognitive loss.

Human safety information is absent: no tolerability trial, no dose-escalation study, no adverse-event registry. The antioxidant effect reported in dishes is also not automatically benign in a living organism, since reactive oxygen species serve as signals in immune defence and in the adaptations that follow exercise.

No human absorption, half-life or clearance measurement for EDR has been published, and nothing establishes whether an intact tripeptide crosses the blood-brain barrier after peripheral administration.

Usually a lyophilised powder, often bundled into "brain" or "longevity" lines alongside Epitalon — two chemically distinct molecules: a three-residue peptide ending in arginine versus a four-residue peptide ending in glycine.

The record is small but better placed than most of the family: Rejuvenation Research is an international peer-reviewed journal, and the 2011 paper carries co-authors from Moscow State University's biology faculty alongside Khavinson. The rest sits in Bulletin of Experimental Biology and Medicine and Advances in Gerontology, much of it in Russian. Publishing in a Western journal is not the same as being replicated, and no unaffiliated laboratory has repeated these results.

For deeper dives on this peptide, see:

• Pinealon benefits and areas of interest
• Pinealon side effects and safety context
• Pinealon dosing concepts (educational)
• Pinealon research and evidence overview

Does Pinealon improve memory or cognition in humans? No published human trial has measured cognition after EDR. Claims about focus, memory or "neuroprotection" are extrapolated from cell cultures deliberately poisoned with oxidants.

Is Pinealon the same as Epitalon? No. Epitalon is Ala-Glu-Asp-Gly and its literature centres on telomerase and lifespan; Pinealon is Glu-Asp-Arg and its literature centres on reactive oxygen species in neural cells. Sellers group them because both trace to pineal research, not because they behave alike.

Does it contain melatonin? No. Melatonin is an indoleamine made from tryptophan and is chemically unrelated to a three-amino-acid peptide; a sleep claim built on that association is a category error.

Is it licensed as a medicine? Not by the FDA, EMA or MHRA. It is distributed as a research chemical, so no authority has reviewed its purity, potency or safety.